Sooma Medical

Founded in 2013.

At home treatment of depression and chronic pain

Soomas innovative treatment of depression and other neurological conditions via transcranial direct current stimulation (tDCS) is set to scale depression treatment to the world. The portable tDCS device and software developed by Sooma bring scientifically validated personalisable treatment to the point of need with fewer side effects in contrast to pharmacological treatment. The company has gained FDA breakthrough device designation in 2023 and reimbursement in Finland and Estonia.